Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Menu

Rx Item-GVOKE GLUCAGON SUBCU SYR BY XERIS PHARMA 1 MG PFS 0.2 ML

GVOKE GLUCAGON SUBCU SYR BY XERIS PHARMA 1 MG PFS 0.2 ML NDC No. 72065-0131-11 72065-131-11 7206513111 72065013111 UPC/GTIN No. 3-72065-13111-2 372065131112 372065-131112    MPN No. 13111NDC No. 72065-0131-11 72065-131-11 7206513111 72065013111 UPC/GTIN No. 3-72065-13111-2 372065131112 372065-131112    MPN No. 13111Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Rx Item-GVOKE GLUCAGON SUBCU SYR BY XERIS PHARMA 1 MG PFS 0.2 ML

$336.96$306.16

NDC No. 72065-0131-11 72065-131-11 7206513111 72065013111 UPC/GTIN No. 3-72065-13111-2 372065131112 372065-131112 MPN No. 13111 Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.Lab, Naturalist, Naturopath, NP, Optometrist, Pharmacist, PA, Physical Therapist, Podiatrist, Research Co., Uni., VA, Vet & Wholesalers In Scope Of their Practice Can Order Rx Item.For:Hypoglycemia
Gvoke (glucagon injection) is a ready-to-use, room-temperature stable, liquid glucagon fo

Have a question?

GVOKE PFS 0.5 MG PRE-FILLED SYRINGE- glucagon injection, solution injection, solution
GVOKE PFS 1 MG PRE-FILLED SYRINGE- glucagon injection, solution injection, solution
GVOKE HYPOPEN 1 MG AUTO-INJECTOR- glucagon injection, solution injection, solution
GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR- glucagon injection, solution injection, solution GVOKE (glucagon injection)

Xeris Pharmaceuticals, Inc.



These highlights do not include all the information needed to use GVOKE safely and effectively. See full prescribing information for GVOKE.

GVOKE (glucagon injection), for subcutaneous use

Initial U.S. Approval: 1960
INDICATIONS AND USAGE

GVOKE is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ages 2 years and above. ( 1)
DOSAGE AND ADMINISTRATION

GVOKE auto-injector and pre-filled syringe are for subcutaneous injection only ( 2.1)
The recommended dose for adults and pediatric patients aged 12 years and older is 1 mg ( 2.2)
The recommended dose for pediatric patients aged 2 to under 12 years of age is weight dependent: ( 2.2)
For pediatric patients who weigh less than 45 kg, the recommended dose is 0.5 mg GVOKE
For pediatric patients who weigh 45 kg or greater, the recommended dose is 1 mg GVOKE
Administer GVOKE according to the printed instructions on the foil pouch label, carton, or the Instructions for Use ( 2.1)
Visually inspect GVOKE prior to administration. The solution should appear clear and colorless to pale yellow and be free of particles. If the solution is discolored or contains particulate matter, do not use ( 2.1)
Administer the injection in the lower abdomen, outer thigh, or outer upper arm ( 2.1)
Call for emergency assistance immediately after administering the dose ( 2.1)
When the patient has responded to treatment, give oral carbohydrates ( 2.1)
Do not attempt to reuse GVOKE. Each GVOKE device contains a single dose of glucagon and cannot be reused ( 2.1)
If there has been no response after 15 minutes, an additional weight appropriate dose of GVOKE from a new device may be administered while waiting for emergency assistance ( 2.2)

DOSAGE FORMS AND STRENGTHS

Injection:

0.5 mg/0.1 mL single-dose pre-filled HypoPen auto-injector ( 3)
1 mg/0.2 mL single-dose pre-filled HypoPen auto-injector ( 3)
0.5 mg/0.1 mL single-dose pre-filled syringe ( 3)
1 mg/0.2 mL single-dose pre-filled syringe ( 3)

CONTRAINDICATIONS

Pheochromocytoma ( 4)
Insulinoma ( 4)
Known hypersensitivity to glucagon or to any of the excipients ( 4)

WARNINGS AND PRECAUTIONS

Catecholamine Release in Patients with Pheochromocytoma: Contraindicated in patients with pheochromocytoma because GVOKE may stimulate the release of catecholamines from the tumor. ( 4, 5.1)
Hypoglycemia in Patients with Insulinoma: In patients with insulinoma, administration may produce an initial increase in blood glucose; however, GVOKE may stimulate exaggerated insulin release from an insulinoma and cause hypoglycemia. If a patient develops symptoms of hypoglycemia after a dose of GVOKE, give glucose orally or intravenously. ( 4, 5.2)
Hypersensitivity and Allergic Reactions: Allergic reactions have been reported and include generalized rash, and in some cases anaphylactic shock with breathing difficulties, and hypotension. ( 4, 5.3)
Lack of Efficacy in Patients with Decreased Hepatic Glycogen: GVOKE is effective in treating hypoglycemia only if sufficient hepatic glycogen is present. Patients in states of starvation, with adrenal insufficiency or chronic hypoglycemia may not have adequate levels of hepatic glycogen for GVOKE to be effective. Patients with these conditions should be treated with glucose ( 5.4)
Necrolytic Migratory Erythema (NME): a skin rash, has been reported postmarketing following continuous glucagon infusion and resolved with discontinuation of the glucagon. Should NME occur, consider whether the benefits of continuous glucagon infusion outweigh the risks. ( 5.5)
Hypoglycemia in Patients with Glucagonoma: Glucagon administered to patients with glucagonoma may cause secondary hypoglycemia. Test patients suspected of having glucagonoma for blood levels of glucagon prior to treatment, and monitor blood glucose levels during treatment. If a patient develops hypoglycemia, give glucose orally or intravenously. ( 5.6)

ADVERSE REACTIONS

Most common adverse reactions (incidence 2% or greater) reported were:
Adults-nausea, vomiting, injection site edema raised 1 mm or greater, and headache ( 6.1)
Pediatric Patients-nausea, hypoglycemia, vomiting, headache, abdominal pain, hyperglycemia, injection site discomfort and reaction, and urticaria ( 6.1)

To report SUSPECTED ADVERSE REACTIONS, contact Xeris Pharmaceuticals at toll-free 1-877-937-4737 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
DRUG INTERACTIONS

Beta-blockers: Patients taking beta-blockers may have a transient increase in pulse and blood pressure. ( 7.1)
Indomethacin: In patients taking indomethacin GVOKE may lose its ability to raise glucose or may produce hypoglycemia. ( 7.2)
Warfarin: GVOKE may increase the anticoagulant effect of warfarin. ( 7.3)

See 17 for PATIENT COUNSELING INFORMATION and FDA?approved patient labeling including Instructions for Use.

Revised: 09/2019

Revised: 9/2019

GVOKE GLUCAGON SUBCU SYR BY XERIS PHARMA 1 MG PFS 0.2 ML NDC No. 72065-0131-11 72065-131-11 7206513111 72065013111 UPC/GTIN No. 3-72065-13111-2 372065131112 372065-131112    MPN No. 13111
Rx Item-GVOKE GLUCAGON SUBCU SYR BY XERI
GVOKE GLUCAGON SUBCU SYR BY XERIS PHARMA 1 MG PFS 0.2 ML NDC No. 72065-0131-11 72065-131-11 7206513111 72065013111 UPC/GTIN No. 3-72065-13111-2 372065131112 372065-131112 MPN No. 13111

NDC No. 72065-0131-11 72065-131-11 7206513111 72065013111 UPC/GTIN No. 3-72065-13111-2 372065131112 372065-131112    MPN No. 13111
Rx Item-GVOKE GLUCAGON SUBCU SYR BY XERI
NDC No. 72065-0131-11 72065-131-11 7206513111 72065013111 UPC/GTIN No. 3-72065-13111-2 372065131112 372065-131112 MPN No. 13111

Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop
AmericanPharmaWholesale.com
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop